CR250117C190000
- 0.31
- 0.000.00%
Crane Newsroom
Crane Is Maintained at Neutral by UBS
Crane Analyst Ratings
Express News | Crane Co : UBS Raises Target Price to $157 From $152
A Piece Of The Puzzle Missing From China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Share Price
Press Release: Crane Company Announces Close of Engineered Materials Divestiture
Express News | Crane Company Announces Close of Engineered Materials Divestiture
U.S. Companies With Potential Pension Risk Transfer Restructuring Opportunities
China Resources Double-Crane Pharmaceutical Passes Generic Drug Evaluation for Pentazocine Injection
At US$154, Is Crane Company (NYSE:CR) Worth Looking At Closely?
China Resources Double-Crane Pharmaceutical Plans Up to 500-Million-Yuan Investment in Financial Products
Zhuzhou Tianqiao Crane Co., Ltd.'s (SZSE:002523) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
CR Double-Crane Pharma Gets Europe's Suitability Certificate for Dienogest
Express News | U.S. Justice Department Says Crane Company Manitowoc to Pay $42.6M for Clean Air Act Violations for Sale of Noncompliant Diesel Engines in Heavy Duty Cranes
Moody's Upgrades National Bank of Canada Long-term Ratings, Ending Review for Upgrade
D.A. Davidson Maintains Crane(CR.US) With Buy Rating, Announces Target Price $185
Blue Cypress Announces SoundPost: Next-Generation Financial Management for Associations
Hiab Enters Into a Strategic HIAB Dealer Agreement With Ring Power Utility | Truck | Crane in the US
Returns Are Gaining Momentum At Crane (NYSE:CR)
CR Double-Crane Pharma's Nine Drugs Chosen in China's Centralized Drug Bid; Shares Down 3%
Here's Why China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt Responsibly